Sirnaomics
1 follower
‌
Sirnaomics is a clinical stage biopharmaceutical company leveraging an outstanding level of knowledge and experience in RNA interference (RNAi) technology to forge a path to high value creation through discovery and development of therapeutics for human disorders with unmet medical needs.
Industries
Headquarters
Employees
Links
Org chart
Patrick Y. Lu
Chairman, President & CEO
Patrick Y. Lu
Collapse
Nigel Yip
Chief Financial Officer
George Ji
Business Administrator
Xianbin Yang
VP, Chief Scientific Officer - China
Yip Wing Kei
VP, Corporate Finance & CFO, China
Edward Wang
VP, Regulatory Compliance & CTO, China
Richard W. Welch
VP, CMC
Jacqueline A. Dombroski
VP, Regulatory Affairs
Jim Weterings
VP, Research, RNA Therapeutics & Delivery
Dai Xiaochang
Executive Director & Chief Strategy Officer
Randy Chen
Senior Director, Bioinformatics, China CIO
